Tipsheet
What matters at India’s listed companies
The Open / 16 Jul 2026 · 8:00 AM IST

M&A, defence orders, and promoter arrests set the tone

Aurum's Housing.com deal, Lokesh's defence order, Mylan dumps Biocon, and promoter arrests at Advik and Carnation

Nifty 500 11,147.55 +0.70%
Nifty Midcap 150 7,757.15 +0.66%
Nifty Smallcap 250 5,861.60 +0.30%
Nifty Microcap 250 24,937.10 0.00%
Major NSE sectoral indices latest
IndexLevelMove
Bank Nifty 56,755.60 -0.58%
Nifty Auto 27,843.90 0.00%
Nifty Energy 38,174.80 0.00%
Nifty Financial Services 28,497.30 0.00%
Nifty FMCG 48,881.20 0.00%
Nifty Healthcare 16,497.70 0.00%
Nifty IT 30,418.35 +3.32%
Nifty Media 1,558.60 0.00%
Nifty Metal 12,400.25 0.00%
Nifty Pharma 25,998.85 +0.20%
Nifty Private Bank 16,648.10 +2.00%
Nifty PSU Bank 8,284.20 0.00%
Nifty Realty 921.45 0.00%
Nifty Cement 15,276.60 0.00%
Nifty Chemicals 30,047.25 0.00%
Nifty Consumer Durables 39,550.80 0.00%
Nifty Oil & Gas 11,067.85 0.00%
Market map
  • Large-cap pharma sees Mylan exit Biocon, a strategic partner departure that weighs on sentiment.
  • Small-cap M&A: Aurum's Housing.com deal is transformational; Shankara's open offer consolidates promoter control.
  • Defence/engineering orders: Lokesh Machines, ITI, and Innovision score meaningful wins.
  • Micro-cap governance: Promoter arrests at Advik and Carnation create binary risk.
  • Capital allocation: Wanbury's early debt redemption, AYE's massive debt raise, Vraj's capex bet.
By size
Large cap 2 Order Wins / Other ₹96,434 cr Small cap 3 M&A / Order Wins ₹8,454 cr Micro cap 9 Other / Order Wins ₹3,148 cr
By sector
Pharmaceuticals 3 Micro cap / Large cap Steel & Iron Products 2 Micro cap Finance - NBFC 2 Micro cap / Small cap IT - Software 1 Small cap Engineering 1 Micro cap Telecom - Equipment 1 Large cap Professional Services 1 Micro cap Castings & Forgings 1 Micro cap
Overnight & on watch14
AURUM M&A Small cap IT - Software

Aurum Proptech Ltd.

Aurum PropTech is buying Housing.com via a ₹458 cr all-share deal, settled entirely in equity. Housing.com's ₹687 cr FY25 revenue dwarfs Aurum's own scale, so this transforms the company into a dominant real-estate tech platform. The heavy dilution of existing holders is the price: promoter warrants signal confidence, but integration risk is high and the stock trades at 868x trailing earnings.

₹458 cr
Acquisition cost for Housing.com,
₹1,651 cr
Small cap mcap
+285.31%
PAT
+82.8%
Rev
0.3x
D/E
1-week price -5.69% · 1wk
Read the note
BIOCON Other Large cap Pharmaceuticals

Biocon Ltd.

Mylan sold its entire 5.64% stake in Biocon for ₹4,000 cr in an open-market sale. The exit of a long-standing biosimilar partner adds a supply overhang for a stock already at 174x trailing earnings with declining profits. The open question is whether this changes the partnership dynamic for future biosimilar launches.

₹4,000 cr
Value of Mylan's entire 5.64%
₹67,454 cr
Large cap mcap
174.93x
P/E
-56.77%
PAT
+2.25%
Rev
0.82x
D/E
1-week price +10.99% · 1wk
Read the note
LOKESHMACH Order Wins Micro cap Engineering

Lokesh Machines Ltd.

Lokesh Machines won a ₹58.2 cr defence order from the Indian Army for machine gun kits, roughly 10% of its market cap. This order validates the company's defence credentials after recently exiting the US sanctions list, a key overhang removal. For a micro-cap with 150x P/E, near-term revenue visibility is now meaningfully better.

₹58.20 cr
Defence order from MoD (Army) for
₹580 cr
Micro cap mcap
150.32x
P/E
+1623.2%
PAT
+53.4%
Rev
0.63x
D/E
1-week price -2.14% · 1wk
Read the note
WANBURY Other Micro cap Pharmaceuticals

Wanbury Ltd.

Wanbury redeemed ₹180 cr of NCDs five years early, eliminating debt equal to about 15% of its market cap. For a micro-cap with 2.92x debt/equity, this sharply reduces interest costs and financial risk. It follows a 24% pledge release last week and confirms management's confidence in cash flows, a significant positive surprise.

₹180 crore
Outstanding principal of NCDs
₹959 cr
Micro cap mcap
22.3x
P/E
+7.15%
PAT
-4.31%
Rev
2.92x
D/E
1-week price +14.12% · 1wk
Read the note
ITI Order Wins Large cap Telecom - Equipment

ITI Ltd.

ITI landed an ₹856 cr BSNL order for 4G site expansion in West India, worth over 3% of its own market cap. The order provides a tangible boost to an order book for a company whose revenue fell 40% last year. Execution across 7,613 sites will be the test, but the win reinforces ITI's role in the government's telecom push.

₹856.39 cr
New BSNL order for 4G expansion
₹28,980 cr
Large cap mcap
98.97x
P/E
+7839.38%
PAT
-39.98%
Rev
0.91x
D/E
1-week price -0.99% · 1wk
Read the note
INNOVISION Order Wins Micro cap Professional Services

Innovision Ltd.

Innovision won a ₹205 cr NHAI toll contract, its largest ever at nearly 30% of market cap. The order pushes visible pipeline well above trailing quarterly revenue of ₹268 cr. After a recent order correction that inflated value, this win builds confidence in NHAI's continued trust and Innovision's execution capabilities.

₹205.20 cr
NHAI toll Contract; 29.6% of Mkt
₹682 cr
Micro cap mcap
18.48x
P/E
+8.33%
PAT
+6.27%
Rev
0.96x
D/E
1-week price +0.26% · 1wk
Read the note
SHANKARA M&A Micro cap Steel & Iron Products

Shankara Building Products Ltd.

Shankara Building Products' promoter trust launched a ₹94.57 cr open offer at ₹150/share to consolidate control to 75.52%. The mandatory offer arises from regulatory non-compliance, a rare event. With public float so reduced, delisting risk now hangs over this nano-cap stock.

₹94.57 cr
Total offer consideration for 26%
₹297 cr
Micro cap mcap
77.37x
P/E
+881.91%
PAT
+4.15%
Rev
0.43x
D/E
1-week price +5.40% · 1wk
Read the note
VRAJ Other Micro cap Steel & Iron Products

Vraj Iron & Steel Ltd.

Vraj Iron & Steel announced a ₹450 cr greenfield plant, exceeding its own ₹391 cr market cap. The company will shift from debt-free to levered with ₹300 cr debt. The Gujarat location and incentives de-risk the project, but execution over 30 months is the critical unknown for a company that has never managed a capex this large.

₹450 cr
Estimated capex for greenfield
₹391 cr
Micro cap mcap
12.21x
P/E
+41.66%
PAT
+11.24%
Rev
0x
D/E
1-week price +29.05% · 1wk
Read the note
ADVIKCA Other Micro cap Finance - NBFC

Advik Capital Ltd.

Advik Capital's promoter was arrested by the Enforcement Directorate. For a ₹76 cr nano-cap NBFC with falling revenue, this is an acute governance shock. The company asserts no material impact, but access to management and control are now uncertain, making sentiment-driven selling almost certain.

₹76 cr
Mkt cap of the nano-cap NBFC
₹78.5 cr
Micro cap mcap
-384.04%
PAT
-122.1%
Rev
0.93x
D/E
1-week price -4.65% · 1wk
Read the note
KOBO Other Micro cap Pharmaceuticals

Kobo Biotech Ltd.

Kobo Biotech's resolution plan missed its 10 July court deadline with no funds received. The ₹70.11 cr infusion, central to the plan, is now in doubt. For a ₹18 cr company already in corporate insolvency, this delay raises the risk of plan collapse and potential liquidation, wiping out residual shareholder value.

₹70.11 cr
Expected infusion under the
₹17.92 cr
Micro cap mcap
-8.4%
PAT
-1.09x
D/E
1-week price +9.87% · 1wk
Read the note
JNKINDIA Order Wins Small cap Engineering - Industrial Equipments

JNK India Ltd.

JNK India lost a ₹100-300 cr Abu Dhabi incinerator order after the licensor blocked approval. The cancelled contract was worth up to 36% of annual revenue, eroding near-term growth visibility. The company says declared revenue is unaffected, but the setback raises questions about execution on international projects.

₹100–300 crore
Order cancelled
₹2,659 cr
Small cap mcap
40.95x
P/E
+149.55%
PAT
+77.25%
Rev
0.01x
D/E
1-week price -6.34% · 1wk
Read the note
YASHHTEJ Other Micro cap Edible Oil

Yashhtej Industries (India) Ltd.

Yashhtej Industries is betting ₹175 cr on a soybean oil plant, 1.5x its own market cap. The Madhya Pradesh incentives de-risk project economics, but the company's debt/equity of 2.23 and trailing revenue of ₹78 cr mean financing is the critical unknown. The market cap is only ₹112 cr, making this a high-stakes bet.

₹175 cr
Proposed investment – over 1.5x
₹112 cr
Micro cap mcap
8.94x
P/E
58.96%
ROE
2.23x
D/E
1-week price -0.22% · 1wk
Read the note
Management changed its story
  • HDB Financial delayed unsecured business loan growth recovery to Q3 FY27 from its earlier guidance of Q1-Q2, without explaining what changed. The Jan 2026 call said growth would return 'in a couple of quarters'; the Jul 2026 call moved the timeline to Q3. Management's visibility claims are undercut.

    HDBFS concall note
  • Jindal Saw claimed it previously guided H1 weakness, but prior calls only flagged Q1-specific impact. The Apr 2026 call mentioned Q1 softness, while Jan 2026 was optimistic on FY27 volumes. This misalignment with earlier commentary raises questions about the quality of guidance.

    JINDALSAW concall note
  • Fedbank revised gold AUM growth guidance upward to 25-30% and mortgage downward to 15-20%, then stated 'we have not changed any guidances.' The contradiction with actual guidance ranges, plus a reversal on LAP yield outlook, makes every forward word suspect.

    FEDFINA concall note
  • MP Bharat Agro repeatedly ruled out equity dilution for its Dhule expansion, saying it would use debt and internal accruals. In Jul 2026, management said a mix of debt and equity is under discussion. The unexplained shift creates uncertainty for existing shareholders.

    MPBHARAT concall note
From the calls
  • HDB Financial's Q1 PAT rose 38% YoY and NIM hit 8.35%, but management pushed unsecured business loan growth to Q3 from earlier Q1-Q2 guidance without clear reasoning. The delay undercuts management's visibility claims and flags a potential slowdown.

    HDBFS concall note
  • Jindal Saw's Q1 PAT fell 78% due to MENA trade freeze and API suspension. Management claimed it had guided H1 weakness, but prior calls mentioned only Q1 impact. The narrative mismatch damages trust; volume recovery depends on MENA resolution and API license reinstatement.

    JINDALSAW concall note
  • Fedbank's gold loan AUM surged 77% YoY, but guidance contradictions, upward revision for gold, downward for mortgage, but denial of any change, erode credibility. Medium-ticket LAP yields face 'substantial drop' from competition, pressuring NIM.

    FEDFINA concall note
  • ICICI Prudential Life's VNB grew 24.9% with margins up 200 bps to 26.7%, driven by 60% retail protection growth. However, management warns H2 protection growth will moderate and refuses to provide full-year guidance, creating a visibility gap.

    ICICIPRULI concall note
On the calendar today
  • IN · Railway Freight · impact L
  • IN · Current Account Balance · prev -1.29% · impact M
  • IN · Corporate Bond Issuance · prev -32.64% YoY · impact M
  • IN · Broad Money Supply (M3) · prev 12.95% YoY · impact M
  • KR · Central Bank Policy Rate · actual 2.75% (prev 2.5%) · impact H